VOYA Investment Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.5M | Buy |
280,354
+220,676
| +370% | +$12.2M | 0.02% | 604 |
|
|
2025
Q1 | $2.89M | Sell |
59,678
-22,949
| -28% | -$1.11M | ﹤0.01% | 1153 |
|
|
2024
Q4 | $3.19M | Sell |
82,627
-31,225
| -27% | -$1.21M | ﹤0.01% | 1119 |
|
|
2024
Q3 | $5.12M | Buy |
113,852
+48,786
| +75% | +$2.2M | 0.01% | 986 |
|
|
2024
Q2 | $2.25M | Sell |
65,066
-4,377
| -6% | -$152K | ﹤0.01% | 1278 |
|
|
2024
Q1 | $2.01M | Buy |
69,443
+26,198
| +61% | +$758K | ﹤0.01% | 1347 |
|
|
2023
Q4 | $992K | Buy |
43,245
+282
| +0.7% | +$6.47K | ﹤0.01% | 1683 |
|
|
2023
Q3 | $717K | Buy |
42,963
+1,374
| +3% | +$22.9K | ﹤0.01% | 1847 |
|
|
2023
Q2 | $1.15M | Sell |
41,589
-52,468
| -56% | -$1.45M | ﹤0.01% | 1589 |
|
|
2023
Q1 | $2.16M | Sell |
94,057
-45,342
| -33% | -$1.04M | ﹤0.01% | 1328 |
|
|
2022
Q4 | $1.52M | Sell |
139,399
-7,060
| -5% | -$77K | ﹤0.01% | 1446 |
|
|
2022
Q3 | $1.23M | Buy |
146,459
+129,091
| +743% | +$1.09M | ﹤0.01% | 1523 |
|
|
2022
Q2 | $137K | Hold |
17,368
| – | – | ﹤0.01% | 2542 |
|
|
2022
Q1 | $411K | Hold |
17,368
| – | – | ﹤0.01% | 2015 |
|
|
2021
Q4 | $594K | Sell |
17,368
-69
| -0.4% | -$2.36K | ﹤0.01% | 1900 |
|
|
2021
Q3 | $309K | Buy |
17,437
+1,187
| +7% | +$21K | ﹤0.01% | 2334 |
|
|
2021
Q2 | $729K | Buy |
16,250
+1,156
| +8% | +$51.9K | ﹤0.01% | 1860 |
|
|
2021
Q1 | $391K | Buy |
15,094
+2,023
| +15% | +$52.4K | ﹤0.01% | 2164 |
|
|
2020
Q4 | $264K | Buy |
13,071
+3,045
| +30% | +$61.5K | ﹤0.01% | 2264 |
|
|
2020
Q3 | $196K | Buy |
+10,026
| New | +$196K | ﹤0.01% | 2163 |
|